Regulatory and licensing risks under the Pharmaceuticals and Medical Devices Act and other laws
First written in FY2022. 1 of 2 entries say "Restated". Latest entry: FY2025.
The whole theme swung hardest in 2021: 2 of 14 companies on the "Worse" side.
16 other companies' latest entry also says "Restated".
- FY2025RestatedAnnual report
「If we are unable to obtain the required permits, designations, registrations or licences, fail to complete renewal or registration/notification procedures, violate amendments to relevant laws and regulations, or if these laws and regulations are amended, this may affect our group’s store-opening plans and performance, among other matters.」
The risk of an impact on store-opening plans and earnings from licences and approvals for pharmacies and nursing care facilities, renewal procedures, legal amendments and violations continues to be disclosed. - FY2022First statedAnnual report
「However, if we are unable to obtain the required permits, designations, registrations or licences, fail to complete renewal or registration/notification procedures, violate amendments to relevant laws and regulations, or if these laws and regulations are amended, this may affect our store-opening plans and performance, among other matters.」
The potential impact of pharmacy establishment permits, health-insurance pharmacy designations and other licences and approvals, as well as legal amendments and procedural deficiencies, on store-opening plans and earnings is disclosed.